These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 11215597)

  • 1. Changes in vocal loudness following intensive voice treatment (LSVT) in individuals with Parkinson's disease: a comparison with untreated patients and normal age-matched controls.
    Ramig LO; Sapir S; Fox C; Countryman S
    Mov Disord; 2001 Jan; 16(1):79-83. PubMed ID: 11215597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up.
    Ramig LO; Sapir S; Countryman S; Pawlas AA; O'Brien C; Hoehn M; Thompson LL
    J Neurol Neurosurg Psychiatry; 2001 Oct; 71(4):493-8. PubMed ID: 11561033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic.
    Wight S; Miller N
    Int J Lang Commun Disord; 2015; 50(2):215-25. PubMed ID: 25469736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Intensive Voice Treatment (The Lee Silverman Voice Treatment [LSVT LOUD]) in Subjects With Multiple Sclerosis: A Pilot Study.
    Baldanzi C; Crispiatico V; Foresti S; Groppo E; Rovaris M; Cattaneo D; Vitali C
    J Voice; 2022 Jul; 36(4):585.e1-585.e13. PubMed ID: 32819780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speech loudness and quality 12 months after intensive voice treatment (LSVT) for Parkinson's disease: a comparison with an alternative speech treatment.
    Sapir S; Ramig LO; Hoyt P; Countryman S; O'Brien C; Hoehn M
    Folia Phoniatr Logop; 2002; 54(6):296-303. PubMed ID: 12417800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
    Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
    J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study.
    El Sharkawi A; Ramig L; Logemann JA; Pauloski BR; Rademaker AW; Smith CH; Pawlas A; Baum S; Werner C
    J Neurol Neurosurg Psychiatry; 2002 Jan; 72(1):31-6. PubMed ID: 11784821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive voice treatment (LSVT®LOUD) for Parkinson's disease following deep brain stimulation of the subthalamic nucleus.
    Spielman J; Mahler L; Halpern A; Gilley P; Klepitskaya O; Ramig L
    J Commun Disord; 2011; 44(6):688-700. PubMed ID: 21724193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivering the Lee Silverman Voice Treatment (LSVT) by web camera: a feasibility study.
    Howell S; Tripoliti E; Pring T
    Int J Lang Commun Disord; 2009; 44(3):287-300. PubMed ID: 18821113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voice quality changes following phonatory-respiratory effort treatment (LSVT) versus respiratory effort treatment for individuals with Parkinson disease.
    Baumgartner CA; Sapir S; Ramig TO
    J Voice; 2001 Mar; 15(1):105-14. PubMed ID: 12269625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Lee Silverman Voice Treatment® LOUD on Japanese-Speaking Patients with Parkinson's Disease.
    Nakayama K; Yamamoto T; Oda C; Sato M; Murakami T; Horiguchi S
    Rehabil Res Pract; 2020; 2020():6585264. PubMed ID: 32411475
    [No Abstract]   [Full Text] [Related]  

  • 13. Perception of Physical Demand, Mental Demand, and Performance: A Comparison of Two Voice Interventions for Parkinson's Disease.
    Richardson K; Huber JE; Kiefer B; Snyder S
    Am J Speech Lang Pathol; 2022 Sep; 31(5):1963-1978. PubMed ID: 35858264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the LSVT on vowel articulation and coarticulation in Parkinson's disease.
    Sauvageau VM; Roy JP; Langlois M; Macoir J
    Clin Linguist Phon; 2015 Jun; 29(6):424-40. PubMed ID: 25688915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of PD Check-In, a model for supported self-managed maintenance of speech in Parkinson's disease: A Phase 1 study.
    Finnimore A; Theodoros D; Rumbach AF
    Int J Lang Commun Disord; 2023 Mar; 58(2):241-255. PubMed ID: 36036751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Lee Silverman Voice Treatment (LSVT LOUD®) on swallowing and cough in Parkinson's disease: A pilot study.
    Miles A; Jardine M; Johnston F; de Lisle M; Friary P; Allen J
    J Neurol Sci; 2017 Dec; 383():180-187. PubMed ID: 29246611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the Lee Silverman Voice Treatment (LSVT® LOUD) on hypomimia in Parkinson's disease.
    Dumer AI; Oster H; McCabe D; Rabin LA; Spielman JL; Ramig LO; Borod JC
    J Int Neuropsychol Soc; 2014 Mar; 20(3):302-12. PubMed ID: 24524211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2011; 46(1):1-16. PubMed ID: 21281410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of group voice therapy for individuals with Parkinson's disease.
    Searl J; Wilson K; Haring K; Dietsch A; Lyons K; Pahwa R
    J Commun Disord; 2011; 44(6):719-32. PubMed ID: 21889774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two forms of intensive speech treatment for Parkinson disease.
    Ramig LO; Countryman S; Thompson LL; Horii Y
    J Speech Hear Res; 1995 Dec; 38(6):1232-51. PubMed ID: 8747817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.